Sensus Healthcare, Inc. (SRTS): Price and Financial Metrics
GET POWR RATINGS... FREE!
SRTS Stock Summary
- Sensus Healthcare Inc's market capitalization of $69,091,504 is ahead of only 10.38% of US-listed equities.
- The ratio of debt to operating expenses for Sensus Healthcare Inc is higher than it is for about just 12.72% of US stocks.
- As for revenue growth, note that SRTS's revenue has grown -53.34% over the past 12 months; that beats the revenue growth of only 6.14% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Sensus Healthcare Inc, a group of peers worth examining would be INUV, MIND, DWSN, SONM, and POAI.
- SRTS's SEC filings can be seen here. And to visit Sensus Healthcare Inc's official web site, go to www.sensushealthcare.com.
SRTS Stock Price Chart Interactive Chart >
SRTS Price/Volume Stats
| Current price | $4.40 | 52-week high | $6.09 |
| Prev. close | $4.38 | 52-week low | $2.32 |
| Day low | $4.24 | Volume | 21,157 |
| Day high | $4.59 | Avg. volume | 289,140 |
| 50-day MA | $3.66 | Dividend yield | N/A |
| 200-day MA | $3.50 | Market Cap | 72.56M |
Sensus Healthcare, Inc. (SRTS) Company Bio
Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides Sentinel service program, which offers its customers protection for their SRT-100 and SRT-100 Vision systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is based in Boca Raton, Florida.
Latest SRTS News From Around the Web
Below are the latest news stories about Sensus Healthcare Inc that investors may wish to consider to help them evaluate SRTS as an investment opportunity.
Is Sensus Healthcare, Inc. (SRTS) A Good Stock To Buy?The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings […] |
Shareholders May Be Wary Of Increasing Sensus Healthcare, Inc.'s (NASDAQ:SRTS) CEO Compensation PackageSensus Healthcare, Inc. ( NASDAQ:SRTS ) has not performed well recently and CEO Joe Sardano will probably need to up... |
Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Lags Revenue EstimatesSensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 22.22% and -22.08%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock? |
Sensus Healthcare Reports First Quarter 2021 Financial ResultsRevenues up 83% year-over-year Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 06, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three months ended March 31, 2021. Highlights from the first quarter of 2021 and recent weeks include the following (all comparisons are with the first quarter of 2020, unless otherwise indicated): Installed the 500th unit since Sensus was founded 10 years ago with the sale of a second unit to Mid-Atlantic Skin Surgery Institute in MarylandResearchers at Colorado State University demonstrated the effectiveness ... |
Sensus Healthcare, Inc. to Host Earnings CallNEW YORK, NY / ACCESSWIRE / May 6, 2021 / Sensus Healthcare, Inc. (NASDAQ:SRTS) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 4:30 PM Eastern Time. |
SRTS Price Returns
| 1-mo | 28.65% |
| 3-mo | -0.90% |
| 6-mo | 22.22% |
| 1-year | 42.39% |
| 3-year | -40.86% |
| 5-year | N/A |
| YTD | 13.99% |
| 2020 | 9.04% |
| 2019 | -52.23% |
| 2018 | 43.60% |
| 2017 | -1.71% |
| 2016 | N/A |
Continue Researching SRTS
Want to see what other sources are saying about Sensus Healthcare Inc's financials and stock price? Try the links below:Sensus Healthcare Inc (SRTS) Stock Price | Nasdaq
Sensus Healthcare Inc (SRTS) Stock Quote, History and News - Yahoo Finance
Sensus Healthcare Inc (SRTS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...